Article

Multi-center, randomized controlled, open evaluation of efficacy and safety of Arbidol hydrochloride tablets in the treatment of influenza-like cases

2023-03-31

Abstract excerpt

<h4>Objective: </h4> To study the efficacy and safety of Arbidol hydrochloride tablets in the treatment of influenza-like cases. <h4>Methods: </h4> A multicenter, randomized controlled, open study was conducted. 412 influenza-like cases were collected from 14 hospitals in 7 regions of Hebei Province from September 2021 to March 2022. They were randomly divided into 2 groups. 207 patients in the control group were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 346bc145-3cf8-515f-8b64-964c4d4da622
DOI: 10.21203/rs.3.rs-2606276/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-center, randomized controlled, open evaluation of efficacy and safety of Arbidol hydrochloride tablets in the treatment of influenza-like casesDOI 10.21203/rs.3.rs-2606276/v1Read

Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19Semantic proximity Read

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read

Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19Semantic proximity Read

Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24.Semantic proximity Read

Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in JapanSemantic proximity Read

The Emergence of Influenza B as a Major Respiratory Pathogen in Absence of COVID-19 During 2021-2022 Flu Season in ChinaSemantic proximity Read

RECOMBINANT HUMAN MONOCLONAL ANTIBODIES CASIRIVIMAB/IMDEVIMAB USE IN INHIBITION OF THE SARS-CoV-2 VIRUS INFECTIONSemantic proximity Read

Real-Life Practice of Kelleni’s Protocol in Treatment and Post Exposure Prophylaxis of SARS CoV-2 Omicron HV.1 and JN.1 SubvariantsSemantic proximity Read

Efficiency of antiviral treatment in COVID‑19Semantic proximity Read

Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsSemantic proximity Read

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitroSemantic proximity Read